Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Methotrexate (MTX) has been increasingly administered to patients with rheumatoid arthritis (RA), resulting in methotrexate-associated lymphoproliferative disorder (MTX-LPD) in patients. We reported three case of rheumatoid arthritis (RA) undergoing methotrexate (MTX) therapy who developed MTX-LPD. A 72-year-old woman treated with MTX since December 1997 (total dose 3684 mg) presented with swelling of the right tonsil in October 2006, and diffuse large B-cell lymphoma was diagnosed by tonsil biopsy and positive EBER1. When MTX therapy was interrupted, the tonsil was shrank and chemotherapy was not necessary. She followed a good clinical course for 12 months. Two other patients treated with MTX for RA for several years presented with enlarged neck lymph nodes and were diagnosed with MTX-LPD. Neck lymph nodes shrank upon MTX withdrawal in several weeks. There have been no signs of recurrence in these cases and they followed a good clinical course. The oncogenic potential of MTX and RA is reviewed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3950/jibiinkoka.111.594 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Methotrexate-Associated Primary Cutaneous Epstein-Barr Virus-Positive Polymorphic B-Cell Lymphoproliferative Disorder With Metachronous T-Cell Clonally Related Angioimmunoblastic T-Cell Lymphoma: A Case Report and Review of the Literature.
Am J Dermatopathol
September 2025
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY.
Primary cutaneous Epstein-Barr virus (EBV)-positive polymorphic B-cell lymphoproliferative disorder (LPD) is a rare LPD associated with iatrogenic and endogenous immune dysregulation with the commonest risk factor being immunosuppressive therapy. We present a 55-year-old woman with rheumatoid arthritis, previously on methotrexate, who developed a waxing and waning papulonodular eruption on the chest and neck. Histopathology revealed a lymphohistiocytic infiltrate with atypical EBV+/CD30+ B cells, consistent with EBV+ polymorphic B-cell LPD.
View Article and Find Full Text PDFMethotrexate-Associated Systemic Lymphadenopathy Exhibiting a Marked Elevation of the Serum IgG4 Concentrations.
Intern Med
August 2025
Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan.
Methotrexate (MTX) is an established anchor drug used for the treatment of rheumatoid arthritis. Patients receiving MTX are at an increased risk of developing MTX-associated lymphoproliferative disorders (MTX-LPDs). A diagnosis of MTX-LPD requires a pathological evaluation; however, biopsy samples are often unavailable because of the anatomical location of the lesions and their rapid regression following MTX withdrawal.
View Article and Find Full Text PDFMethotrexate-associated Hodgkin Lymphoma Occurring Decades after Methotrexate Initiation.
JMA J
July 2025
Department of General Medicine, National Defense Medical College, Saitama, Japan.
[Successful treatment with cyclosporine for central nervous system disorder caused by Epstein-Barr virus meningitis in other iatrogenic immunodeficiency-associated lymphoproliferative disorder].
Rinsho Ketsueki
August 2025
Department of Hematology, Izumiotsu Medical Center.
Methotrexate-associated lymphoproliferative disorder (MTX-LPD) with central nervous system (CNS) disorder caused by Epstein-Barr virus (EBV) infection is very rare. We report a case of other iatrogenic immunodeficiency-associated lymphoproliferative disorder (OII-LPD) with EBV meningitis in an 83-year-old woman. She was diagnosed with rheumatoid arthritis and treated with MTX for 10 years.
View Article and Find Full Text PDFProtracted Tonsillitis as an Atypical Initial Manifestation of Methotrexate-Induced EBV-Positive Lymphoproliferative Disorder in Rheumatoid Arthritis: A Case Report and Literature Review.
Diagnostics (Basel)
June 2025
Department of Otolaryngology, Tungs' Taichung MetroHarbor Hospital, Taichung 435, Taiwan.
Methotrexate is widely used as a disease-modifying antirheumatic drug for rheumatoid arthritis (RA), yet prolonged immunosuppression may lead to rare complications, including Epstein-Barr virus (EBV)-positive lymphoproliferative disorders (LPDs). We present the case of a 70-year-old woman with RA on chronic immunosuppressive therapy who developed symptoms resembling recurrent tonsillitis. CT imaging revealed bilateral necrotic palatine tonsils and extensive necrotic lymphadenopathy involving the cervical, mediastinal, and axillary regions.
View Article and Find Full Text PDF